Evonik Industries/€EVK

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About Evonik Industries

Evonik Industries AG, a German multinational, specializes in producing specialty chemicals, primarily focusing on consumer goods, animal nutrition, and pharmaceuticals. Founded in 1873, the company operates globally and is structured into multiple segments including Specialty Additives, Nutrition & Care, and Smart Materials among others. As a publicly traded entity, it is listed on the Frankfurt Stock Exchange under the ticker EVK.

Ticker

€EVK
Sector

Primary listing

XETRA

Industry

Chemicals
Headquarters

Employees

31,585

ISIN

DE000EVNK013
Website

EVK Metrics

BasicAdvanced
€8.5B
28.26
€0.64
0.95
€1.17
6.43%

What the Analysts think about EVK

Analyst ratings (Buy, Hold, Sell) for Evonik Industries stock.

Bulls say / Bears say

Evonik Industries plans to boost its core profit by €1 billion by 2027 through business growth and cost savings, including €500 million from internal growth and €500 million from an optimization program. (reuters.com)
The company reported a margin increase to 15% in Q3 2024, showing improvement despite flat or slightly declining volumes, indicating effective cost-saving initiatives. (gurufocus.com)
Evonik has defined three new innovation growth areas: biosolutions, circular economy, and energy transition, aiming for €1.5 billion in new sales by 2032, positioning itself in high-growth markets. (gurufocus.com)
Evonik reported a net loss of €465 million in 2023 due to high impairments and structural measures, reflecting financial challenges. (evonik.com)
The company announced up to 2,000 job cuts worldwide by 2026 to reduce costs by €400 million annually, indicating significant restructuring efforts. (reuters.com)
Evonik does not expect an economic recovery during 2024, suggesting continued market challenges and potential impact on financial performance. (evonik.com)
Data summarised monthly by Lightyear AI. Last updated on 6 Jun 2025.

EVK Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

EVK Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €EVK

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs